Testosterone therapy and the pathogenesis of Kennedy's disease (X-linked bulbospinal muscular atrophy)

Journal of the Neurological Sciences

Volumn 135, Issue 2, 1996, Pages 158-161

  Goldenberg, James N ^a,b   Bradley, Walter G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Anabolic steroids; Androgen receptor; Kennedy's disease; Testosterone; X linked spinal and bulbar atrophy

Indexed keywords

ANDROGEN RECEPTOR; TESTOSTERONE;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE MUTATION; HUMAN; MALE; MUSCLE ATROPHY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030023666     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(95)00285-A     Document Type: Article

References (25)

1. Arbizu T., Santamaria J., Gomez J.M., Quilez A., Serra J.P. (1983) A family with adult spinal and bulbar muscular atrophy, X-linked inheritance and associated testicular failure. J. Neurol. Sci., 59: 371-382.
2. Biancalana V., Serville F., Prommier J., et al. (1992) Moderate instability of trinucleotide repeat in spinobulbar muscular atrophy. Hum. Mol. Genet., 1: 255-258.
3. Demura T., Kuzumaki N., Oda A., Fujita H. (1989) T. Establishment and characterization of monoclonal antibody against androgen receptor. J. Steroid Biochem., 33: 845-851.
4. Dowben R.M., Perlstein M.A. (1961) Muscular dystrophy treated with norethandrolene. Arch. Int. Med., 107: 245-251.
5. Edwards A., Hammond H.A., Caskey C.T., Chakraborty R. (1992) Population genetics of trimeric and tetrameric repeats in four human ethnic groups. Genomics, 12: 241-253.
6. Fillyaw M.J., Badger G.J., Goodwin G.D., Bradley W.G. (1991) The effects of long-term non-fatiguing resistance exercise in subjects with post-polio syndrome. Orthopedics, 14(11): 1253-1256.
7. Fischbeck K. (1993) DNA expansion syndromes. Genetics in Neurology (American Academy of Neurology Course). 75-81.
8. Forbes G.B. (1985) The effect of anabolic steroids on lean body mass: the dose-response curve. Metabolism, 34: 571-573.
9. Griggs R.C., Kingston W., Jozefowicz R.F., Herr B.E., Forbes G., Halliday D. (1989a) Effect of testosterone on muscle mass and muscle protein synthesis. J. Appl. Physiol., 66(1): 498-503.
10. Griggs R.C., Pandya S., Florence J.M., et al. (1989b) Randomized controlled trial of testosterone in myotonic dystrophy. Neurology 39: 219-222.
11. Grino B.J., Isidro-Gutierrez R.F., Griffin J.E. and Wilson J.D. (1989) Androgen resisitance associated with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy. J. Clin. Endocrinol. Metab., 68: 578-584.
12. Hoagland C.L., Golder H., Shank R.E. (1945) The synthesis, storage, and excretion of creatine, creatinine, and glycocyamine in progressive muscular dystrophy and the effects of certain hormones on these processes. J. Exp. Med., 81: 423-438.
13. Kennedy W.R., Alter M., Sung J.H. (1968) Progressive proximal and spinal bulbar muscular atrophy of late onset: a sex linked recessive trait. Neurology, 18: 671-680.
14. Kolkin S., Barohn R.J., Kudsk K.A., Hyser C.L., Mendell J.R. (1987) The effects of transcutaneous muscle stimulation and testosterone on strength and muscle mass in myotonic dystrophy [abstract]. Neurology, 37 (Suppl. 1): 209.
15. Kurz E.M., Sangelaub D.R., Arnold A.P. (1986) Androgens regulate the dendritic length of mammalian motor neurons in adulthood. Science, 232: 395-398.
16. LaSpada A.R., Wilson E.M., Lubahn D.B., Harding A.E., Fischbeck K.H. (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature, 352: 77-79.
17. Matsuura T., Demura T., Aimoto Y., Mizono T., Moriwaka F., Tashiro K. (1992) Androgen receptor abnormality in the X-linked spinal and bulbar muscular atrophy. Neurology, 42(9): 1724-1726.
18. McPhaul M.J., Marcelli M., Tilley W.D., Griffin J.E. (1991) Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy. J. Clin. Invest., 87(4): 413-421.
19. Mhatre A.N., Trifiro M.A., Kaufman M. et al. (1993) Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nature Genetics, 5: 184-187.
20. Nakamura M., Mita S., Murakami T., et al. (1993) Exonic trinucleotide repeats and expression of androgen receptor gene in spinal cord from X-linked spinal and bulbar muscular atrophy. Ann. Neurol., 34: 261.
21. Perlstein M.A., Gutterman H. (1950) Testosterone in progressive pseudo-hypertrophic muscular dystrophy. J. Pediatr., 37: 743-749.
22. Romshe C.A., Sotos J.F. (1980) The combined effect of growth hormone and oxandrolone in patients with growth hormone deficiency. J. Pediatr., 96: 127-131.
23. Sar M., Stumpf W.E. (1977) Androgen concentration in motor neurons of cranial nerves and spinal cord. Science, 197: 77-79.
24. Sobue G., Doyu M., Morishima T., et al. (1994) Aberrant androgen action and increased size of tandem CAG repeat in androgen receptor gene in X-linked recessive bulbospinal neuronopathy. J. Neurol. Sci., 121: 167-171.
25. Yu W.A. (1989) Administration of testosterone attenuates neuronal loss following axotomy in the brain-stem motor nuclei of female rats. J. Neurosci., 9(11): 3908-3914.